PALBO-125
Product Code: 1
Pack Size: 21's
- Price: $76.36 ৳8400 ,
Each capsule contains Palbociclib INN 125 mg capsule.
Palbociclib is indicated for the treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer in combination with: • An aromatase inhibitor as initial endocrine-based therapy in postmenopausal women or in men; or • Fulvestrant in patients with disease progression following endocrine therapy.
Major Ingredients
Each capsule contains Palbociclib INN 125 mg capsule.
Major Functionality
Palbociclib is indicated for the treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer in combination with: • An aromatase inhibitor as initial endocrine-based therapy in postmenopausal women or in men; or • Fulvestrant in patients with disease progression following endocrine therapy.
Manufacture Information
Drug International Limited was incorporated under the Registrar of Joint Stock Companies in 1974 as a Private Limited Company. The company commenced formulation and production in 1983 and emerged as a pioneer in Bangladesh for adding a state of the art oral solid dosage plant. Since inception, Drug International Limited's primary objective has been to meet guidelines provided by major global regulatory bodies such as the World Health Organization Good Manufacturing Practices (WHO cGMP) guidelines.
